SOCM
SR One Capital Management Portfolio holdings
AUM
$461M
This Quarter Return
+6.56%
1 Year Return
+23.25%
3 Year Return
+188.96%
5 Year Return
–
10 Year Return
–
AUM
$204M
AUM Growth
+$204M
(+4.6%)
Cap. Flow
+$16.4M
Cap. Flow
% of AUM
8.04%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
–
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Arcellx
ACLX
$3.85B
| $99.4M | 48.67% |
5,500,007
| – | – |
|
2
Design Therapeutics
DSGN
$315M
| $78.8M | 38.55% |
5,626,476
| – | – |
|
3
Nkarta
NKTX
$151M
| $16.4M | 8.04% |
+1,333,333
| New | +$16.4M |
|
|
EFTR
4
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $9.69M | 4.74% |
6,822,114
| – | – |
|